Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 250 participants.

Also called NCT06693011

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 250 participants (planned count) (from the registry)
Sponsor
Cerus Endovascular, Inc. (from the registry)
Registry
  • NCT NCT06693011
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06693011. Allocation not applicable; no masking; primary purpose treatment. Start 2025-06-10 (actual); primary completion 2028-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)
Acronym
NEXT
Condition
Cerebral Aneurysms
Intervention (Device)
Contour Neurovascular System Treatment Attempt
Lead sponsor
Cerus Endovascular, Inc. (class: industry)

Record details

Record id
cardio:ct-nct06693011
Content hash
6fe64d84df7e1f654f105633460f1c56a8bef75e97d29c60c3e4eeb552735926